Care of the infant with inherent metabolic disease

Mark Smith1

  • 1Paediatric Intensive Care Unit, Birmingham Children's Hospital.

Paediatric Nursing
|June 13, 2008
PubMed

Insights

Early detection and management of metabolic crises in infants with treatable inherited metabolic diseases are vital for good outcomes. Nurses play a key role in monitoring, support, and managing diet and fluids for these children.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Nursing Care

Background:

  • Inherited metabolic diseases require prompt intervention to prevent crises.
  • Advances in technology lead to earlier diagnosis and increased survival rates in affected children.
  • Nursing care is essential for managing these complex pediatric conditions.

Purpose of the Study:

  • To highlight the critical role of early detection and management of metabolic crises.
  • To define the multifaceted nursing responsibilities in caring for infants with inherited metabolic diseases.
  • To address the evolving needs of surviving children requiring ongoing care.

Main Methods:

  • Literature review on current nursing practices for inherited metabolic diseases.
  • Analysis of technological advancements impacting diagnosis and survival.
  • Discussion of essential nursing interventions including monitoring, support, and fluid/dietary management.

Main Results:

  • Early detection and management significantly improve outcomes for infants with treatable metabolic diseases.
  • Nursing interventions are crucial for monitoring, support, and managing fluid and dietary needs.
  • Increased survival necessitates expanded nursing care across diverse healthcare settings.

Conclusions:

  • Prompt identification and management of metabolic crises are paramount for favorable outcomes.
  • Nurses provide essential monitoring, support, and management crucial for infants with inherited metabolic diseases.
  • The expanding population of survivors will require comprehensive nursing care in various settings.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...